Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials

Alphabet's Isomorphic Labs just raised $2.1 billion to enhance AI-driven drug discovery and move toward clinical trials. This funding will accelerate their efforts to bring AI innovations into the pharmaceutical space.